Anti Aging Skin Care Product Secrets Revealed

Rule #1: Look beyond the claims of the productWhile advertising is a huge influence in the skin care market, it is important to be wise in dealing with the claims of any one particular product. If the product claims to reduce fine lines and eliminate wrinkles are these claims supported by reviews of real people who have used the product and seen positive results?One tip is to look for products that stimulate collagen production as over time, this can bring about dramatic and changes in the skin’s appearance. In addition, a product which contains a good moisturizer is crucial to relax skin tension and lock the moisture in.Rule #2: Don’t worry about the presence of any one ingredientWith so many competing creams on the market, there’s bound to be some degree of separation in which ingredients they all contain. Instead of getting fixated on which product a skin cream “must” contain, try to see what any individual product can bring to your skin care routine.It’s probably too much to ask for any one skin care product to be a “magic pill” for your skin, but by using a combination of products that attack the problem from different angles its easy to see how by using two or even three good skin care products your skin can easily benefit from the compound effect of all the extra nutrients and ingredients.Some really great nutrients for skin care include Silica, Zinc, Omega-3 acids, Selenium and Vitamin C and antioxidants.Rule #3: Avoid IrritantsOk, so while it can be good to have a range of essential nutrients in your skin care regime, there are definitely some skin care products that you would do well to avoid. Products that irritate the skin can actually increase wrinkles and weaken the skin against protection from environmental damage, such as UV from the sun’s rays, which is most definitely NOT what you want!The best advice here is to test. Even the slightest tingling or uncomfortable feeling on the skin resulting from using a product is the first sign of skin irritation. If this happens to you then my advice is strongly to stop using that product immediately! There are many alternatives on the market and the risks are simply not worth the cost.Once again check the product reviews and see what others are saying. This could save you a lot of trouble in the long run.Rule #4: Look for products that compliment your skin typeGetting to know your skin type can save you a lot of time in choosing the right products for you. This is actually a lot easier than you might expect. Basically, skin types can be broken down into four key groups: Normal, dry, oily and sensitive. There is also a combination skin type, although this is less common. Your skin will probably fall into one of these categories or have characteristics which make it more one than the other.(One quick tip here, if you are having trouble undermining your skin type, it could pay to to visit a dermatologist who can easily tell you which category your skin type fits into.)With this in mind, match the right skin product to your skin type and it will not only leave your skin feeling more fresh and nourished but will avoid any harmful influences that may occur from using the wrong product on your skin.In addition to this, remember to use the product on all areas of your skin that are exposed to the sun. It’s often overlooked that it’s not only the areas around the eyes and mouth that need attention. Your neck, hands and even parts of your body such as your knees and elbows may also benefit from some tender love and care!Rule #5: Don’t Expect Results OvernightThis goes back to the promises and claims you will see that accompany many skin care products. If I found a product that was a “miracle cure” for skin care I’d be absolutely thrilled about it! The truth is that a skin care product works in connection with your daily routine and is not really an isolated cure all by itself. You still need to protect yourself from the sun and keep on practising all the good habits which lead to healthy looking skin.That’s not to say that you can’t see tangible results and have great success with the right product. After all, skin care needn’t be difficult and it’s certainly possible to see positive results in a matter of weeks with the right product.Typically, in 2-3 weeks you should start to see some benefits to your skin, although for the best results a more prolonged use is recommended. Using the right product for a few months can literally transform the skin’s appearance.The benefits of a good anti aging skin care product include smoother and more radiant skin, a more even skin tone and less reduction of wrinkles and fine lines. Not only are these goals achievable but thanks to the recent developments in the cosmetics industry they are now also within anyone’s reach.The truth is that anti aging skin care needn’t be expensive or take lots of hard work. However, there is also a LOT of information out there and it can often be tricky to sort out what works from what doesn’t. So, to give you a head start, I’ve put together a free report of neat tips that can help you to have softer, smoother looking skin which feel great in the shortest time possible!First, head on over to How To Have Perfect Skin (that’s the blog) and sign up for my FREE skin care report. You’ll get access to all kinds of info, packed with skin care tips and advice for younger looking skin.Second, browse around the site for more skin care tips, techniques and reviews of and anti aging skin care products that have proven results.Third, take the plunge! By making healthy lifestyle choices and choosing the right product you could start to see significant results towards younger looking skin in less time than you might expect.

What Are the Key Contributors of the Growing Demand For Pharmacy Technicians?

There are quite a number of positive developments which affect the increase of pharmacist Technicians in the past decades, some of them are:1. The gain of national certification on pharmacy Technician career and job has opened up a lot of opportunities for those who have the interest to become assistant to a pharmacist.2. The development of model curriculums for Pharmacy Technician training and a higher and greater level of recognition of pharmacy technicians in the State and Nation wide on pharmacy practice Acts have encouraged many potentials to seek for new employment opportunities as well as to seek for pharmacy technician’s courses in colleges or online.3. The roles and responsibilities of Pharmacy technicians have been more clearly defined in hospital, community centre, clinics and wherever the skill sets of pharmacy technicians are needed.
4. Increasingly, hospital pharmacies are encouraged to develop pharmacy technician programs and the increase changes being called out to ensure the roles of these technicians was appropriately articulated in state laws and regulations.5. The responsibilities of this professions have increased over the years from initially they are responsible for most of the clerical work only in the pharmacy ( similar to a clerk) … until they start to play the governance role for the state pharmacy association as well as the state board of pharmacy.6. The enablement of pharmacy asistants across multiple settings today, including community pharmacy, hospitals and health systems, long term care facilities, clinic pharmacies, health insurance companies, pharmaceutical whole-salers etc signify that this is a profession which is largely needed in a good wide spread of industry.7. In the recent years, pharmacists have become more receptive to pharmacy technicians compared to 15 years back where the latter is given the task of dispensing medicine only. However much has changed over the last few years in the potential increased in job scopes of pharmacy technicians.8. The enhancement in medical field has enabled new medications, antidotes to be invented across the world by the medical experts. This has significantly reduced non fatal deaths, reduce or eliminate significant pain of patients with this invention. With the prolonged age of the population in the society today, the demand for pharmacy technicians have significantly being increased as well.9. On the other hand, with the increase invention of of new medications invested and become available today, the pharmacists are faced with a greater number of prescriptions to dispense. This has directly reduced the bandwidth of the pharmacists, leaving them with lesser time for counseling patients. At the same time, their working conditions and schedules have deteriorated with an increase in job stress. This is where the importance of the pharmacy technicians comes into picture and they presence has helped to take over the tasks of dispensing the prescriptions to the patients.Pharmacy assistants as such has gained it popularity increasing nowadays and it is by no mistake on the increased demand of pharmacy technicians in many health sectors in the society today.

S&P 500 Biotech Giant Vertex Leads 5 Stocks Showing Strength

Your stocks to watch for the week ahead are Cheniere Energy (LNG), S&P 500 biotech giant Vertex Pharmaceuticals (VRTX), Cardinal Health (CAH), Steel Dynamics (STLD) and Genuine Parts (GPC).

X
While the market remains in correction, with analysts and investors wary of an economic downturn, these five stocks are worth adding to watchlists. S&P 500 medical giants Vertex and Cardinal Health have been holding up, as health-care related plays tend to do well in down markets.

Steel Dynamics and Genuine Parts are both coming off strong earnings as both the steel and auto parts industries report optimistic outlooks. Meanwhile, Cheniere Energy saw sales boom in the second quarter as demand in Europe for natural gas continues to grow.

Major indexes have been making rally attempts with the Dow Jones and S&P 500 testing weekly support on Friday. With market uncertainty, investors should be ready for follow-through day breakouts and keep an eye on these stocks.

Cheniere Energy, Cardinal Health and VRTX stock are all on IBD Leaderboard.

Cheniere Energy Stock
LNG shares rose 1.1% to 175.79 during Friday’s market trading. On the week, the stock advanced 3.1%, not from highs, bouncing from its 21-day and 10-week lines earlier in the week.

Cheniere Energy has been consolidating since mid-September, but needs another week to forge a proper base, with a potential 182.72 buy point formed on Aug. 10.

Houston-based Cheniere Energy was IBD Stock Of The Day on Thursday, as the largest U.S. producer of liquefied natural gas eyes strong demand in Europe.

Even though natural gas prices are plunging in the U.S. and Europe, investors still see strong LNG demand for Cheniere and others.

The U.K. government confirmed last week that it is in talks for an LNG purchase agreement with a number of companies, including Cheniere.

In the first half of 2021, less than 40% of Cheniere’s cargoes of LNG landed in Europe. That jumped to more than 70% through this year’s second quarter, even as the company ramped up new export capacity. The urgency of Europe’s natural gas shortage only intensified last month. That is when an explosion disabled the Nord Stream 1 pipeline from Russia that had once supplied 40% of the European Union’s natural gas.

In Q2, sales increased 165% to $8 billion and LNG earned $2.90 per share, up from a net loss of $1.30 per share in Q2 2021. The company will report Q3 earnings Nov. 3, with investors seeing booming profits for the next few quarters.

Cheniere Energy has a Composite Rating of 84. It has a 98 Relative Strength Rating, an exclusive IBD Stock Checkup gauge for share price movement with a 1 to 99 score. The rating shows how a stock’s performance over the last 52 weeks holds up against all the other stocks in IBD’s database. The EPS rating is 41.

Vertex Stock
VRTX stock jumped 3.4% to 300 on Friday, rebounding from a test of its 50-day moving average. Shares climbed 2.2% for the week. Vertex stock has formed a tight flat base with an official buy point of 306.05, according to MarketSmith analysis.

The stock has remained consistent over recent weeks, while the relative strength line has trended higher. The RS line tracks a stock’s performance vs. the S&P 500 index.

Vertex Q3 earnings are on due Oct. 27. Analysts see EPS edging up 1% to $3.61 per share with sales increasing 16% to $2.2 billion, according to FactSet.

The Boston-based global biotech company dominates the cystic fibrosis treatment market. Vertex also has other products in late-stage clinical development that target sickle cell disease, Type 1 diabetes and certain genetically caused kidney diseases. That includes a gene-editing partnership with Crispr Therapeutics (CRSP).

In early August, Vertex reported better-than-expected second-quarter results and raised full-year sales targets.

S&P 500 stock Vertex ranks second in the Medical-Biomed/Biotech industry group. VRTX has a 99 Composite Rating. Its Relative Strength Rating is 94 and its EPS Rating is 99.

CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures?

Cardinal Health Stock
CAH stock advanced 3.2% to 73.03 Friday, clearing a 71.22 buy point from a shallow cup-with-handle base and hitting a record high. But volume was light on the breakout. CAH stock leapt 7.3% for the week.

Cardinal Health stock’s relative strength line has also been trending up for months.

The cup-with-handle base is part of a base-on-base pattern, forming just above a cup base cleared on Aug. 11.

Cardinal Health, based in Dublin, Ohio, offers a wide assortment of health care services and medical supplies to hospitals, labs, pharmacies and long-term care facilities. The company reports that it serves around 90% of hospitals and 60,000 pharmacies in the U.S.

S&P 500 stock Cardinal Health will report Q1 2023 earnings on Nov. 4. Analysts forecast earnings falling 26% to 96 cents per share. Sales are expected to increase 10% to $48.3 billion, according to FactSet.

Cardinal Health stock ranks first in the Medical-Wholesale Drug/Supplies industry group, ahead of McKesson (MCK), which is also showing positive action. CAH stock has a 94 Composite Rating out of 99. It has a 97 Relative Strength Rating and an EPS rating of 73.

Steel Dynamics Stock
STLD shares shot up 8.5% to 92.92 on Friday and soared 19% on the week, coming off a Steel Dynamics earnings beat Wednesday night.

Shares blasted above an 88.72 consolidation buy point Friday after clearing a trendline Thursday. STLD stock is 17% above its 50-day line, definitely extended from that key average.

Steel Dynamics’ latest consolidation could be seen as part of a larger base going back six months.

Steel Dynamics topped Q3 earnings views with EPS rising 10% to $5.46 while revenue grew 11% to $5.65 billion. The steel producer’s outlook is optimistic despite weaker flat rolled steel pricing. STLD reports its order activity and backlogs remain solid.

The Fort Wayne, Indiana-based company is among the largest producers of carbon steel products in the U.S. It engages in metal recycling operations along with steel fabrication and produces myriad steel products.

How Millett Grew Steel Dynamics From A Three Employee Business

STLD stock ranks first in the Steel-Producers industry group. STLD stock has a 96 Composite Rating out of 99. It has a 90 Relative Strength Rating, an exclusive IBD Stock Checkup gauge for share-price movement that tops at 99. The rating shows how a stock’s performance over the last 52 weeks holds up against all the other stocks in IBD’s database. The EPS rating is 98.

Genuine Parts Stock
GPC stock gained 2.8% to 162.35 Friday after the company topped earnings views with its Q3 results on Thursday. For the week GPC advanced 5.1% as the stock held its 50-day line and is in a flat base.

GPC has an official 165.09 flat-base buy point after a three-week rally, according to MarketSmith analysis.

The relative strength line for Genuine Parts stock has rallied sharply to highs over the past several months.

On Thursday, the Atlanta-based auto parts company raised its full-year guidance on growth across its automotive and industrial sales.

Genuine Parts earnings per share advanced 19% to $2.23 and revenue grew 18% to $5.675 billion in Q3. GPC’s full-year guidance is now calling for EPS of $8.05-$8.15, up from $7.80-$7.95. The company now forecasts revenue growth of 15%-16%, up from the earlier 12%-14%.

During the Covid pandemic, supply chain constraints caused a major upheaval in the auto industry, sending prices for new and used cars to record levels. This has made consumers more likely to hang on to their existing vehicles for longer, driving mileage higher and boosting demand for auto replacement parts.

Fellow auto stocks O’Reilly Auto Parts (ORLY) and AutoZone (AZO) have also rallied near buy points amid the struggling market. O’Reilly reports on Oct. 26.

IBD ranks Genuine Parts first in the Retail/Wholesale-Auto Parts industry group. GPC stock has a 96 Composite Rating. Its Relative Strength Rating is 94 and it has an EPS Rating of 89.